Evidence map›Paper›PMID 42328995›Full record

ArticleActa dermato-venereologica2026

"Drug Reaction with Eosinophilia and Systemic Symptoms" (DRESS): Long-term Outcomes Based on Severity - A Cohort Study.

Anika Lipinski, Maren Paulmann, Sabine Müller, Dirk Wagner, Maja Mockenhaupt

Abstract read
In one paragraph

Article in Acta dermato-venereologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anika LipinskiDokumentationszentrum schwerer Hautreaktionen (dZh), Freiburg, Germany.
Maren PaulmannDokumentationszentrum schwerer Hautreaktionen (dZh), Freiburg, Germany.
Sabine MüllerDepartment of Dermatology, Medical Centre - University of Freiburg, Freiburg, Germany.
Dirk WagnerDivision of Infectious Diseases, Department of Internal Medicine II, Medical Centre - University of Freiburg, Freiburg, Germany; Department of Epidemiology, Helmholtz Centre for Infection Research Braunschweig, Braunschweig, Germany.
Maja MockenhauptDokumentationszentrum schwerer Hautreaktionen (dZh), Freiburg, Germany; Department of Dermatology, Medical Centre - University of Freiburg, Freiburg, Germany. dzh@uniklinik-freiburg.de.ORCID 0000-0002-6596-1684

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe drug-induced reaction characterized by exanthema, eosinophilia and organ involvement. Patients reported sequelae comprising skin or organ alterations and autoimmune diseases. We investigated long-term complications of patients included in the German Registry of severe skin reactions between 2003 and 2023 with a definite or probable diagnosis of DRESS using a follow-up questionnaire. Cases were classified by severity (mild, moderate-to-severe) employing 2 scores (drug-induced liver injury [DILI] and acute kidney injury [AKI]). In total, 36/61 questionnaires (59%) were analysed revealing an equal distribution: 18 mild and 18 moderate-to-severe cases. All patients experienced long-term complications. Skin disorders occurred in 81%, mucosal problems in 31% and hair/nail complications in 43%. Severity groups were equally affected, whereas laboratory abnormalities appeared more often in moderate-to-severe cases. Haematological abnormalities were most frequently observed (94%), followed by elevated liver enzymes (88%) and impaired renal function parameters (31%). Alterations of HbA1c occurred in 16% and abnormal thyroid function in 19%, including 2 cases of Graves' disease. Intolerance reactions to other medication were observed in 27% of cases, explaining fear of further medication (51%) and resulting avoidance behaviour (49%).

Indexed as

Acute Kidney InjuryChemical and Drug Induced Liver InjuryDrug Hypersensitivity SyndromeAdolescentAdultAgedAged, 80 and overFemaleGermanyHumansMaleMiddle AgedRegistriesRisk FactorsSeverity of Illness IndexSurveys and Questionnaires

Identifiers

PMID42328995
PMCPMC13284849

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.